Market Overview

Aprea Therapeutics Opens Above IPO Price


Aprea Therapeutics, Inc. (NASDAQ: APRE) made its public debut Thursday morning, opening at $15.46 after being priced at $15 per share.

The shares are listed on the Nasdaq under the ticker symbol “APRE.”

Aprea Therapeutics is a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53.

JPMorgan, Morgan Stanley and RBC Capital Markets are acting as joint book-running managers for the offering.

Related Links:

IGM Biosciences Opens Above IPO Price

Ping Identity Holding Opens Above IPO Price

Posted-In: News IPOs


Related Articles (APRE)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at